Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

A new class of GABA receptor ligands claimed by Neurogen

Feb. 4, 1997

AHP claims smooth muscle cell proliferation inhibitors

Feb. 4, 1997

Merck & Co. continues to develop farnesyl protein transferase inhibitors

Feb. 4, 1997

Piperidine derivatives reported by Schering-Plough

Feb. 4, 1997

Betulinic acid derivatives reported to have anti-HIV activity

Feb. 4, 1997

Pfizer claims glycogen phosphorylase inhibitors

Feb. 4, 1997

Sankyo prepares prostaglandin derivatives for ulcers

Feb. 3, 1997

Hypoglycemic/hypolipidemic agents from Sumitomo Metal

Feb. 3, 1997

NOS inhibitors described by JT

Feb. 3, 1997

Anti-HIV agents from Shionogi

Feb. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...